Abstract
Objective: To elaborate a proposal of Clinical Protocol of Pharmaceutical Care for Individuals with Diabetes Mellitus. Methods: The present work was carried out in the form of qualitative research, with descriptive character for elaboration of the clinical protocol following the Dáder Methodology. Scientific information was collected from using Internet databases such as Periódicos Capes and Biblioteca Virtual em Saúde (BVS). Current scientific papers (2007-2019 period) were selected. Results: The Protocol of Pharmaceutical Care was developed according to the Dáder Methodology of Pharmaco-therapeutic Follow-up, based on information about Diabetes Mellitus, with the purpose of assembling a competent tool that assists in the treatment, adherence of the patient, and provide guidelines for it. Conclusion: It can be concluded that the Clinical Protocol for Pharmaceutical Care contains important information and guidance about the disease and treatment to identify and prevent drug-related problems, which include adverse reactions and drug interactions. However, it is expected that this proposal of care protocol will help the pharmaceutical professionals, during the service of pharmacotherapeutic follow-up of individuals with Diabetes Mellitus, seeking to support this process, bringing benefits to the health of the population.